[Chemotherapy in cancers of the colon].
Seitz
J F
JF
Unité de Gastroentérologie et d'Oncologie Digestive, Institut Paoli-Calmettes, Marseille.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000628:therapy*; D005472:Fluorouracil / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007372:Interferons / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use; D002955:Leucovorin / Q000627:therapeutic use*; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D007376:Interleukin-2; D001224:Aspartic Acid; C013195:sparfosic acid; D007372:Interferons; D010746:Phosphonoacetic Acid; D002955:Leucovorin; D005472:Fluorouracil